US regulator to recruit 50 new gene and cell therapy clinical reviewers
January 16, 2019Research and Development FDA, cell therapy, gene therapy, regulation
FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …
MSD’s Keytruda boosts overall survival by 31% in advanced oesophageal cancer
January 16, 2019Research and Development Cancer, MSD, keytruda, oesophageal cancer, pharma
MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …
Breast cancer cells can be transformed into fat cells using combination therapy, study shows
January 16, 2019Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours
An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …
Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific
January 16, 2019Manufacturing and Production, Medical Communications, Research and Development DKSH, Novo Nordisk, pharma
DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …
FDA halts allergy drug approval process due to government shutdown
January 15, 2019Research and Development Aimmune, FDA, Trump, governmetn, shutdown
California-based pharma firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration …
Former CEO of Novartis’ US operations joins board of cancer immunotherapy firm
January 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …
Tumours with large number of mutations respond better to immunotherapies, study shows
January 15, 2019Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour
Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …
Verona’s shares drop 34% on Phase 2 failure of nebulised ensifentrine in COPD
January 15, 2019Manufacturing and Production, Research and Development Boehringer, COPD, Stiolto Respimat, pharma, trial failure, verona pharma
Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …
Dutch health minister attacks Novartis over orphan drug price hike
January 15, 2019Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …
Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer
January 15, 2019Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma
Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …
US Lawmaker launches investigation into pharma pricing practices
January 15, 2019Manufacturing and Production Bernie Sanders, Elijah cummings, congress, pharma, pricing, us politics
Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …
AstraZeneca’s chief medical officer announces resignation amid wave of departures
January 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …
Living with Alström syndrome
January 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease
Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …
Seqirus secures first cell-based quadrivalent influenza vaccine approval in Europe
January 14, 2019Sales and Marketing Europe, Flucelvax, flu, influenza, pharma, seqirus
Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …
Teva settles $135 million dollar fraud case over Medicaid price inflation
January 14, 2019Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing
Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …
Government appoints health minister from firm trying to win NHS contracts
January 14, 2019Sales and Marketing NHS, corruption, digital, government, online, politics
The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister …
EMA approves more new active substances in 2018, but total recommendations fall
January 14, 2019Sales and Marketing EMA, EU, Europe, drug approvals, pahrma
2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines …
Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV
January 14, 2019Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis
The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …
Kyowa Hakko Kirin signs drug discovery deal with AI firm InveniAI
January 11, 2019Medical Communications, Research and Development AI, InveniAI, Kyowa Hakko Kirin, artificial intelligence, drug discovery, pharma
Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …
Top Ten most popular articles on Pharmafile.com this week!
January 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10
With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
